Literature DB >> 28050101

Lissencephaly with agenesis of corpus callosum: A rare anomaly.

V K Maurya1, M Bhatia1, R Ravikumar2, K P S Senger3.   

Abstract

Entities:  

Keywords:  Corpus callosal agenesis; Lissencephaly; MRI

Year:  2016        PMID： 28050101      PMCID： PMC5192207          DOI： 10.1016/j.mjafi.2016.03.013

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  7 in total

1.  Magnetic resonance imaging in classification of congenital muscular dystrophies with brain abnormalities.

Authors:  M S van der Knaap; L M Smit; P G Barth; C E Catsman-Berrevoets; O F Brouwer; J H Begeer; I F de Coo; J Valk
Journal:  Ann Neurol       Date:  1997-07       Impact factor: 10.422

2.  Clinical features of 21 patients with lissencephaly type I (agyria-pachygyria).

Authors:  M Ozmen; Y Yilmaz; M Calişkan; O Minareci; N Aydinli
Journal:  Turk J Pediatr       Date:  2000 Jul-Sep       Impact factor: 0.552

3.  Developmental aspects of lissencephaly and the lissencephaly syndromes.

Authors:  W B Dobyns
Journal:  Birth Defects Orig Artic Ser       Date:  1987

4.  Genotypically defined lissencephalies show distinct pathologies.

Authors:  Mark S Forman; Waney Squier; William B Dobyns; Jeffrey A Golden
Journal:  J Neuropathol Exp Neurol       Date:  2005-10       Impact factor: 3.685

Review 5.  Prenatal US and MR imaging findings of lissencephaly: review of fetal cerebral sulcal development.

Authors:  Sandeep Ghai; Katherine W Fong; Ants Toi; David Chitayat; Sophia Pantazi; Susan Blaser
Journal:  Radiographics       Date:  2006 Mar-Apr       Impact factor: 5.333

6.  The spectrum of lissencephaly: report of ten patients analyzed by magnetic resonance imaging.

Authors:  A J Barkovich; T K Koch; C L Carrol
Journal:  Ann Neurol       Date:  1991-08       Impact factor: 10.422

7.  Epidemiology of lissencephaly type I.

Authors:  J F de Rijk-van Andel; W F Arts; A Hofman; A Staal; M F Niermeijer
Journal:  Neuroepidemiology       Date:  1991       Impact factor: 3.282
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.